TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Lonza Group Ltd ( (CH:LONN) ) has provided an update.
Lonza Group Ltd has announced a capital decrease through the destruction of 1,997,163 shares, which were repurchased as part of its 2023-2025 share buyback program. This move reduces the company’s share capital from CHF 72,226,184.00 to CHF 70,229,021.00, potentially enhancing shareholder value and optimizing capital structure.
More about Lonza Group Ltd
Lonza Group Ltd is a leading company in the life sciences industry, primarily focusing on providing contract development and manufacturing services for pharmaceuticals and biotechnology companies. The company is known for its expertise in producing biologics, small molecules, and cell and gene therapies, serving a global market.
Find detailed analytics on LONN stock on TipRanks’ Stock Analysis page.